Vanguard Group’s HCW Biologics HCWB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-243,158
| Closed | -$68.6K | – | 4297 |
|
|
2025
Q1 | $68.6K | Buy |
243,158
+205,481
| +545% | +$57.9K | ﹤0.01% | 4170 |
|
|
2024
Q4 | $16.8K | Hold |
37,677
| – | – | ﹤0.01% | 4265 |
|
|
2024
Q3 | $20.3K | Hold |
37,677
| – | – | ﹤0.01% | 4302 |
|
|
2024
Q2 | $24.4K | Buy |
37,677
+28
| +0.1% | +$18 | ﹤0.01% | 4348 |
|
|
2024
Q1 | $65.9K | Sell |
37,649
-167,493
| -82% | -$293K | ﹤0.01% | 4284 |
|
|
2023
Q4 | $251K | Buy |
205,142
+523
| +0.3% | +$641 | ﹤0.01% | 4185 |
|
|
2023
Q3 | $389K | Buy |
204,619
+17,528
| +9% | +$33.3K | ﹤0.01% | 4126 |
|
|
2023
Q2 | $406K | Buy |
187,091
+5,218
| +3% | +$11.3K | ﹤0.01% | 4176 |
|
|
2023
Q1 | $255K | Hold |
181,873
| – | – | ﹤0.01% | 4281 |
|
|
2022
Q4 | $348K | Buy |
181,873
+86,481
| +91% | +$166K | ﹤0.01% | 4192 |
|
|
2022
Q3 | $218K | Buy |
95,392
+8,494
| +10% | +$19.4K | ﹤0.01% | 4403 |
|
|
2022
Q2 | $191K | Buy |
86,898
+4,377
| +5% | +$9.62K | ﹤0.01% | 4474 |
|
|
2022
Q1 | $225K | Hold |
82,521
| – | – | ﹤0.01% | 4519 |
|
|
2021
Q4 | $191K | Buy |
+82,521
| New | +$191K | ﹤0.01% | 4561 |
|